Scientists have uncovered a way to make existing antifungal drugs work again against deadly, drug-resistant fungi. Fungal infections claim millions of lives worldwide each year, and current medical ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after ...

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

One of the hallmarks of Alzheimer's disease is the clumping of proteins called Tau, which form tangled fibrils in the brain. The more severe the clumping, the more advanced the disease is.

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

Persistent pharmaceutical residues such as carbamazepine are increasingly detected in natural waters, posing long-term ecological and human health risks due to their resistance to conventional ...

A team from the Universitat Politècnica de València (UPV) has led the development of a new sensor capable of quickly and ...

In a remarkable twist of science, researchers have transformed a fungus long associated with death into a potential weapon against cancer. Found in tombs like that of King Tut, Aspergillus flavus was ...

Terray Therapeutics has achieved its first discovery milestone in the company’s multi-target collaboration with Bristol Myers Squibb (BMS). Under the terms of the agreement, which began in 2023, ...

Troops could one day carry portable devices to detect the “chemical fingerprint” of hazardous substances in the field, thanks to a system developed by Army researchers at Aberdeen Proving Ground, in ...

For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration. “The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch.

The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...